Beilu Pharma - About the company
Beilu Pharma is an unfunded company based in Beijing (China), founded in 1992. It operates as a Manufacturer of contrast media, anti-diabetic drugs, anti-anxiety medicine, and APIs. Beilu Pharma has not raised any funding yet. The company has 49 active competitors, including 5 funded and 10 that have exited. Its top competitors include companies like AmerisourceBergen, Dizal Pharma and Guiyang Xintian Pharmaceutical.
Company Details
Manufacturer of contrast media, anti-diabetic drugs, anti-anxiety medicine, and APIs. The company provides contrast media products for diagnostic imaging and interventional therapy. Anti-diabetic drugs, including tablets, are available for type 2 diabetes. An anti-anxiety traditional Chinese medicine is also offered. Intermediates and excipients are available. Specialities include cisternography, myelography, ventriculography, angiography, and sialography.
Key Metrics
Founded Year
1992
Location
Beijing, China
Stage
Unfunded
Ranked
15th among 49 active competitors
Employee Count
72 as on Aug 31, 2026
Similar Companies
Sign up to download Beilu Pharma's company profile
Beilu Pharma's funding and investors
Beilu Pharma has not raised any funding rounds yet.
Beilu Pharma's founders and board of directors
Founder? Claim ProfileBeilu Pharma's employee count trend
Beilu Pharma has 72 employees as of Aug 26. Here is Beilu Pharma's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Beilu Pharma's Competitors and alternates
Top competitors of Beilu Pharma include AmerisourceBergen, Dizal Pharma and Guiyang Xintian Pharmaceutical. Here is the list of Top 10 competitors of Beilu Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AmerisourceBergen 1985, Chesterbrook (United States), Public | Drug Corporation | - | 68/100 | |
2nd | Dizal Pharma 2017, Pudong (China), Series A | Limited information available | $100M | 50/100 | |
3rd | Guiyang Xintian Pharmaceutical 1995, Guiyang (China), Public | Pharmaceutical company in China | - | 39/100 | |
4th | Quanyuantang Pharmacy 1902, Chengdu (China), Series C | Retailer of medical and pharmaceutical product | $76M | 35/100 | |
5th | Sinopharm Online 2015, Minhang (China), Series B | Pharmaceutical e-commerce platform | $62.4M | 32/100 | |
6th | Zhejiang Conba Pharmaceutical 2002, Hangzhou (China), Deadpooled | Limited information available | - | 31/100 | |
7th | Zhejiang Zuoli Pharmaceutical 1999, Huzhou (China), Public | Distributor of pharmaceutical products | - | - | 30/100 |
8th | Sinco Pharmaceuticals Holdings 2016, Chengdu (China), Unfunded | Pharmaceutical company that provides marketing, promotion, and channel management services | - | - | 29/100 |
9th | PAM²L Biotechnologies 2021, China, Seed | Supplier and wholesaler of bio-pharmaceutical products | $14.8M | 28/100 | |
10th | Sinopharm Accord Pharmaceutical 1985, Shenzhen (China), Public | Retailer of pharmaceutical products | - | - | 27/100 |
15th | Beilu Pharma 1992, Beijing (China), Unfunded | Manufacturer of contrast media, anti-diabetic drugs, anti-anxiety medicine, and APIs | - | - | 24/100 |
Looking for more details on Beilu Pharma's competitors? Click here to see the top ones
Beilu Pharma's Investments and acquisitions
Beilu Pharma has made no investments or acquisitions yet.
Reports related to Beilu Pharma
Here is the latest report on Beilu Pharma's sector:
News related to Beilu Pharma
•
Chongqing Three Gorges A (000565.sz) Plans To Reduce Its Holdings Of No More Than 3 Million Shares Of Beilu PharmaceuticalInvesting•Feb 28, 2025•Beilu Pharma, Snowball
•
Qihe Biosciences Completes Over RMB 200 Million Series A FinancingYaorongyun Digital Technology•Dec 21, 2024•Qi Biodesign, Chang Development, Beilu Pharma, CD Capital and 2 others
•
This pharmaceutical company announced a 2.02 billion yuan acquisition plan: accounting for 80% of the sharesPencilNews•Apr 16, 2024•Beilu Pharma, Jinan Wanhang International Logistics
•
Chinese Biotech Firm Varnotech Snaps $84m Series B FundingShareandstocks•Mar 25, 2024•Beijing Huanuotai Biomedical Technology, Beilu Pharma, Varni Tech, 3E Bioventures Capital
Are you a Founder ?
FAQs about Beilu Pharma
Explore our recently published companies
- Lexmind AI - Dortmund based, Unfunded company
- LifeFrom AI - Sheridan based, Unfunded company
- ProcOS AI - Unfunded company
- AI Solutions - United Kingdom based, Unfunded company
- Shadowless Headlights Dr. Kim - Czech Republic based, Unfunded company
- Lektorat AI - Fort Lauderdale based, 2025 founded, Unfunded company
